| Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE): updated standing orders for ST-segment elevation myocardial infarction and unstable angina/non-ST-segment elevation myocardial infarction. | |
| | |
MedLine Citation:
|
PMID: 20520214 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) acute coronary syndromes critical pathway toolkit has been updated based on the 2009 focused updates of the American College of Cardiology/American Heart Association guidelines for the management of patients with ST-segment elevation myocardial infarction (STEMI) and American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions guidelines on percutaneous coronary intervention (PCI). This review highlights the major changes cited in the focused updates, which have been incorporated into the STRIVE standing orders for STEMI and unstable angina/non-ST-segment elevation myocardial infarction (UA/NSTEMI). The updated STEMI and UA/NSTEMI standing orders and other tools are available to clinicians online on the STRIVE Web site. |
| | |
Authors:
|
Christopher P Cannon |
Related Documents
:
|
18278214 - Determinants of final infarct size and incidence of aborted infarction in patients trea... 10499704 - Electrocardiographic manifestations: acute myopericarditis. 2644054 - Heart rate adjustment of st segment depression for improved detection of coronary arter... 7596024 - New markers of remote ischemia in patients with evolving inferior myocardial infarction. 16226744 - Effects of kr-32570, a new sodium hydrogen exchanger inhibitor, on myocardial infarctio... 12643384 - Late outcome after arterial switch operation for complete transposition of great arteri... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Critical pathways in cardiology Volume: 9 ISSN: 1535-2811 ISO Abbreviation: Crit Pathw Cardiol Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-06-03 Completed Date: 2010-09-22 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101165286 Medline TA: Crit Pathw Cardiol Country: United States |
Other Details:
|
Languages: eng Pagination: 55-81 Citation Subset: IM |
Affiliation:
|
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. cpcannon@partners.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Coronary Syndrome
/
prevention & control,
therapy* Angina, Unstable / therapy* Angioplasty, Transluminal, Percutaneous Coronary Anticoagulants / administration & dosage Critical Pathways* Heparin / administration & dosage Humans Myocardial Infarction / prevention & control, therapy* Myocardial Reperfusion / methods Platelet Aggregation Inhibitors / administration & dosage Practice Guidelines as Topic* Risk Assessment Thrombolytic Therapy / contraindications, standards* Ticlopidine / administration & dosage, analogs & derivatives |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 0/Platelet Aggregation Inhibitors; 55142-85-3/Ticlopidine; 9005-49-6/Heparin; 90055-48-4/clopidogrel |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pathway for the Management of Survivors of Out-of-Hospital Cardiac Arrest.
Next Document: Depression as Modifiable Coronary Risk Factor in the Emergency Department Chest Pain Observation Uni...